Tag: bruton’s tyrosine kinase inhibitors (BTKi)
Pirtobrutinib is safe and efficacious in the treatment of relapsed or refractory B-cell malignancies (BRUIN Trial)
1. Bruton’s tyrosine kinase inhibitor pirtobrutinib showed efficacy in the treatment of relapsed or refractory B-cell malignancies such as chronic ...
Popular Reports
-
Automated pupillometry may be helpful in opioid agonist therapy dosing for opioid use disorder
-
Ultrasound features associated with shoulder complaints
-
#VisualAbstract: Adequate antibody response to mRNA-1273 COVID-19 vaccine occurs in patients with cancer
-
#VisualAbstract High cost of healthcare was the highest patient-reported barrier to accessing outpatient dermatologic care
-
Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.